Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netildex gel after microincisional vitreoretinal surgery
2008-005082-64Phase 2Completed
- Sponsor
- SIFI SpA
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of netilmicin + dexamethasone, dexamethasone, netilmicin and tobramycin in Postoperative ocular inflammation (2 arms), sponsored by SIFI SpA. Primary endpoint: Bulbar conjunctival hyperaemia at Visit 4. Started Mar 2009; status: completed.
02
Drugs
netilmicin + dexamethasonedexamethasonenetilmicintobramycin
03
Conditions
Postoperative ocular inflammation
Beyond the preview
Go deeper on 2008-005082-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005082-64.